Regional Dynamics Shaping the Parkinson’s Market: Why APAC, Europe, and North America Lead in Therapeutics Growth The Parkinson’s therapeutics market is shaped by regional differences in demographics, healthcare, and regulation. Each region—North America, Europe, APAC—contributes uniquely, with growth opportunities and challenges driving the global landscape.
North America leads (30%+ global sales), fueled by awareness, early diagnosis, and access to premium therapies (DBS implants). Its...